Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson’s Disease Dual Target Ligands
暂无分享,去创建一个
M. Natália D. S. Cordeiro | Maykel Cruz-Monteagudo | Fernanda Borges | Eduardo Tejera | Yunierkis Perez-Castillo | Aminael Sánchez-Rodríguez | Aliuska Morales Helguera | Cesar Paz-y-Miño | M. Cruz-Monteagudo | M. Cordeiro | A. M. Helguera | E. Tejera | A. Sánchez-Rodríguez | Y. Pérez-Castillo | C. Paz-y-Miño | M. N. D. Cordeiro | Fernanda Borges
[1] D. Frank Hsu,et al. Consensus Scoring Criteria for Improving Enrichment in Virtual Screening , 2005, J. Chem. Inf. Model..
[2] Stephani Joy Y Macalino,et al. Role of computer-aided drug design in modern drug discovery , 2015, Archives of Pharmacal Research.
[3] Hanoch Senderowitz,et al. SeleX-CS: A New Consensus Scoring Algorithm for Hit Discovery and Lead Optimization , 2009, J. Chem. Inf. Model..
[4] Georgios Archontis,et al. Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines. , 2014, Bioorganic & medicinal chemistry.
[5] Thomas J. Crisman,et al. Which aspects of HTS are empirically correlated with downstream success? , 2008, Current opinion in drug discovery & development.
[6] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[7] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[8] Tian Zhu,et al. Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. , 2013, Journal of medicinal chemistry.
[9] Leonardo L. G. Ferreira,et al. Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.
[10] Chang-Guo Zhan,et al. Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening. , 2015, Journal of medicinal chemistry.
[11] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[12] Miklos Feher,et al. Consensus scoring for protein-ligand interactions. , 2006, Drug discovery today.
[13] Xin Chen,et al. Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking , 2011, J. Chem. Inf. Model..
[14] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[15] M. Youdim,et al. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases , 2005, Mechanisms of Ageing and Development.
[16] Shu Liu,et al. Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against β-Secretase (BACE-1) , 2012, PloS one.
[17] J. Gaddum,et al. The Pharmacological Basis of Therapeutics , 1966 .
[18] M. Cordeiro,et al. Discovery of MAO-B inhibitors - present status and future directions part I: oxygen heterocycles and analogs. , 2012, Mini reviews in medicinal chemistry.
[19] M. Schwarzschild,et al. Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists. , 2003, Bioorganic & medicinal chemistry.
[20] Andreas Bender,et al. Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..
[21] Jessica Holien,et al. Improvements, trends, and new ideas in molecular docking: 2012–2013 in review , 2015, Journal of molecular recognition : JMR.
[22] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[23] Simona Distinto,et al. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? , 2008, J. Comput. Aided Mol. Des..
[24] Walter Cabri,et al. Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors. , 2013, Journal of medicinal chemistry.
[25] Maykel Cruz-Monteagudo,et al. Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance? , 2014, Molecular Diversity.
[26] Jiro Shimada,et al. Bootstrap-Based Consensus Scoring Method for Protein-Ligand Docking , 2008, J. Chem. Inf. Model..
[27] A Lavecchia,et al. Virtual screening strategies in drug discovery: a critical review. , 2013, Current medicinal chemistry.
[28] Osmar Norberto de Souza,et al. Discovery of New Inhibitors of Mycobacterium tuberculosis InhA Enzyme Using Virtual Screening and a 3D-Pharmacophore-Based Approach , 2013, J. Chem. Inf. Model..
[29] C. Müller,et al. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. , 1997, Journal of medicinal chemistry.
[30] Neal Castagnoli,et al. Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease , 2011, Neurotherapeutics.
[31] Robert P. Sheridan,et al. Protocols for Bridging the Peptide to Nonpeptide Gap in Topological Similarity Searches , 2001, J. Chem. Inf. Comput. Sci..
[32] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[33] Werner J Geldenhuys,et al. Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease? , 2007, Parkinsonism & related disorders.
[34] I. Kuntz,et al. DOCK 6: combining techniques to model RNA-small molecule complexes. , 2009, RNA.
[35] Pankaj R. Daga,et al. Structure-Based Virtual Screening of the Nociceptin Receptor: Hybrid Docking and Shape-Based Approaches for Improved Hit Identification , 2014, J. Chem. Inf. Model..
[36] Kenji Matsuno,et al. Identification of a New Series of STAT3 Inhibitors by Virtual Screening. , 2010, ACS medicinal chemistry letters.
[37] M. Natália D. S. Cordeiro,et al. Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands , 2015, J. Chem. Inf. Model..
[38] Sonja Hinz,et al. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones. , 2013, Journal of medicinal chemistry.
[39] Markus Lill,et al. Virtual screening in drug design. , 2013, Methods in molecular biology.